Arla gets first approval for new food

The approval comes months after the ingredient received a favorable response from the European Food Standards Agency (EFSA) as a novel food (NF) in various applications back in April 2022. The agency described the ingredient as “safe under the proposed conditions of use​” in isotonic and sports drinks, whey powder and milk-based drinks and in food for special medical purposes (FSMP).

The ingredient offers a unique nutritional composition with 40% more BCAAs than “normal” whey protein and 45% more leucine, which are key in triggering muscle protein synthesis, making it particularly relevant for people focusing on muscle health.

Mads Dyrvig, head of sales development, health and performance at Arla Foods Ingredients, tells NutraIngredients that the low content of selected minerals, including phosphorus, also makes it ideal for patients with chronic kidney disease.

“To achieve a similar amino acid composition, the only option to date has been to supplement your proteins with single free amino acids – characterized by taste challenges,” he adds“In other words, it’s now possible to get a protein with a superior amino acid composition without compromising taste.”

With formal regulatory approval of Lacprodan BLG-100 from the EC, Dyrvig says Arla expects many of its customers to bring new products to market soon.

“The geographic relevance of Lacprodan BLG-100 is global, but the EU, US, China and Japan are initially the primary scope.”

Leave a Comment

Your email address will not be published. Required fields are marked *